Oncology

Latest News

Within 5 years, the risk of SCC in particular was heightened among patients with MMP. | Image credit: wavebreak3 - stock.adobe.com
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers

April 21st 2025

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.

AI technology | Image: Adobe Stock
Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

April 17th 2025

IVBM Atlanta | Image credit: AJMC
Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

April 9th 2025

AJMC
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

April 4th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Site Logo
July 3rd 2017

New Flow Cytometry-Based Test Approved for Certain Leukemias and Lymphomas

Surabhi Dangi-Garimella, PhD
A new liquid biopsy test that uses flow cytometry to detect cancer cells has been FDA approved for chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative neoplasms.
Dr Scott Ramsey Addresses the Need for Differential Pricing Structures for Drugs
July 2nd 2017

Dr Scott Ramsey Addresses the Need for Differential Pricing Structures for Drugs

Differential pricing structures are necessary for products with surrogate endpoints and to account for revolutionizing treatments in order to have a more sustainable value equation, according to Scott Ramsey, MD, PhD, of Fred Hutchinson Cancer Research Center.
This Week in Managed Care: June 30, 2017
June 30th 2017

This Week in Managed Care: June 30, 2017

This week, the top managed care news included the Senate announcing it would delay voting on the healthcare bill until after July 4; the FDA outlined a plan to expedite drug approvals; and Joe and Jill Biden launched the Biden Cancer Initiative.
Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects
June 30th 2017

Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects

As a cancer survivor, Rose Gerber, director of patient advocacy for the Community Oncology Alliance, is personally aware of the many long-term issues that can arise during survivorship. These can include physical effects like bone health and emotional issues like the fear of recurrence.
Site Logo
June 29th 2017

Novel Antibody May Restore Immune Response to Rituximab for CLL

Christina Mattina
Among a group of patients with chronic lymphocytic leukemia (CLL) who were previously unresponsive to rituximab, a new antibody could help enable the immune system to attack the cancer cells, according to a study in PLOS One.
Site Logo
June 29th 2017

Evidence-Based Oncologyâ„¢ Looks at Increasing Use of Palliative Care

Palliative care offers the chance to boost the quality of cancer care, but outdated beliefs that these services should not start until the end of life limit its use. The current issue of Evidence-Based Oncology™, a publication of The American Journal of Managed Care®, explores ways to bring palliative care to more patients who need it.
Site Logo
June 29th 2017

Radiotherapy Reduces Risk of Breast Cancer Mortality, Increases Risks of Other Cancers

Alison Rodriguez
Radiotherapy is responsible for a significant reduction in breast cancer mortality. However, the treatment may lead to the development of a different cancer or heart disease in the future.
Site Logo
June 28th 2017

Hypofractionated Radiation Proves Effective as Prostate Cancer Therapy

Christina Mattina
New research finds that hypofractionated radiation therapy is as effective as conventional radiation for treating prostate cancer while offering more convenience for patients.
Site Logo
June 28th 2017

Nivolumab Improved Patient-Reported QOL Compared With Investigator's Choice: CheckMate 141

Surabhi Dangi-Garimella, PhD
The study, published in Lancet Oncology, has found that nivolumab reduced the rate of clinically meaningful deterioration compared with investigator’s choice among platinum-refractory patients being treated for recurrent or metastatic head and neck cancer.
Site Logo
June 27th 2017

Research Finds Diabetes Drugs, Diet, and Alcohol Affect Breast Cancer Prevention

Alison Rodriguez
Several studies looked at older diabetes drugs for possible effects on breast cancer prevention, as well as the effects of diet and alcohol use on breast cancer risk.
Site Logo
June 27th 2017

Infusing a Sense of Urgency in Cancer Care: The Biden Cancer Initiative

Surabhi Dangi-Garimella, PhD
On Monday, June 26, 2017, the Biden Foundation announced the launch of the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.
Site Logo
June 27th 2017

FDA Plan to Boost Drug Competition Includes Expedited Generic Approval Pathway

Christina Mattina
As part of its new Drug Competition Action Plan, the FDA has announced it will seek to spur innovation by allowing for accelerated approvals of generic drugs without competitors. It also published a list of drugs without approved generics that could be eligible for this expedited review process.
Site Logo
June 27th 2017

Venclexta/Venclyxto Effective in Treating Chronic Lymphocytic Leukemia

Alison Rodriguez
Data from multiple studies have demonstrated the efficacy of Venclexta/Venclyxto in treating relapsed or refractory chronic lymphocytic leukemia, according to Roche.
Site Logo
June 26th 2017

Study Links Medicaid Cuts to More Late-Stage Breast Cancer Diagnoses

Christina Mattina
A new study finds an association between Medicaid disenrollment in Tennessee and higher rates of late-stage breast cancer diagnoses and delays to treatment.
Site Logo
June 26th 2017

Understanding Stakeholder Objectives, and Aligning Them, in Cancer Care

Surabhi Dangi-Garimella, PhD
At the 8th Annual Oncology Market Access & Pricing USA 2017 meeting hosted by eyeforpharma, the discussion included raw material short supplies, pragmatic trials, risk-sharing, and understanding these challenges to meet stakeholder goals.
Site Logo
June 25th 2017

Diagnostic Immunoassays Could Spare Patients High-Risk Pancreatic Resection

Surabhi Dangi-Garimella, PhD
Researchers at Indiana University have confirmed the clinical utility of 2 laboratory tests that can distinguish benign pancreatic cancer lesions that mimic early signs of cancer and spare patients of unnecessary pancreatic cancer screenings or surgeries.
Site Logo
June 25th 2017

US Multi-Society Task Force's New Colorectal Cancer Screening Recommendations

Alison Rodriguez
The US Multi-Society Task Force recently released new recommendations for colorectal cancer (CRC) screenings. Since there has been an increase in CRC among younger Americans, while incidences in those over age 50 is decreasing, the recommendations consider the importance of systematic screening tests even for people without any CRC symptoms.
Site Logo
June 24th 2017

FDA Approves Rituxan Hycela for Treating Certain Blood Cancers

Alison Rodriguez
The FDA has approved Genentech’s Rituxan Hycela for subcutaneous injection for the treatment of certain blood cancers. Rituxan Hycela has similar outcomes as Rituxan, but can be delivered in 5 to 7 minutes compared with 1.5 hours for Rituxan.
Site Logo
June 23rd 2017

FDA Approves of Darzalex Combination for Multiple Myeloma

Alison Rodriguez
The FDA has approved the use of Janssen Biotech, Inc’s immunotherapy Darzalex in combination with pomalidomide and dexamethasone. Darzalex is used to treat multiple myeloma patients who have previously received at least 2 therapies with lenalidomide and a proteasome inhibitor.
Site Logo
June 23rd 2017

Family History, Mutation Location Increase Risks of Breast, Ovarian Cancers

Alison Rodriguez
Researchers investigating the risks of breast, ovarian, and contralateral breast cancer for mutation carriers found that family history and mutation position are important for determining cancer risk estimates, according to a study published in JAMA.
Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives
June 23rd 2017

Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives

Oncologists envision a move towards using data to become a learning health system, which is aided by the changing landscape emphasizing quality and value, explained Bobby Green, MD, MSCE, senior vice president of clinical oncology at Flatiron Health.
Site Logo
June 22nd 2017

Dr Yousuf Zafar of Duke Cancer Institute Joins The Samfund's Advisory Council

AJMC Staff
Yousuf Zafar, MD, will advise The Samfund on research and evaluation of data to enhance its ability to combat financial aftereffects of cancer treatment.
Site Logo
June 22nd 2017

Mutation Burden and PD-L1 Expression Influence Response to Nivolumab in NSCLC

Christina Mattina
A new study in the New England Journal of Medicine has found that a combination of tumor mutation burden and expression of the programmed death ligand-1 (PD-L1) can predict patient response to nivolumab in non—small-cell lung cancer (NSCLC).
Site Logo
June 22nd 2017

Developing a Creative Strategy to Present the Value of Oncology Drugs

Surabhi Dangi-Garimella, PhD
At the 8th Annual Oncology Market Access & Pricing USA 2017 meeting hosted by eyeforpharma, Sriram Shankar, senior consultant, INC Strategy Consulting, shared his thoughts on the implications of value frameworks for payer strategy.
Site Logo
June 21st 2017

Research Warns Patients of Drug-Drug and Herb-Drug Interactions

Christina Mattina
When undergoing therapy for cancer, patients must be aware of the risks of adverse interactions between the therapy and any other drugs or herbal supplements they take, a new study cautions.
Site Logo
June 20th 2017

Asian Women Face Greater Barriers to Follow-up Care on Abnormal Mammogram

Surabhi Dangi-Garimella, PhD
According to a research study published in the journal Cancer, Asian women are less likely than non-Hispanic white women to receive timely follow-up after an abnormal screening mammogram.
Site Logo
June 20th 2017

VA Pharmacy System Requires New Capabilities to Better Serve Veterans

Alison Rodriguez
A new report from the United States Government Accountability Office is calling for pharmacy systems to better serve veterans through additional capabilities for viewing, exchanging, and using data.
Site Logo
June 19th 2017

Diagnostic Test Brings a Precision Medicine Approach to Prostate Cancer Drug

Surabhi Dangi-Garimella, PhD
A collaborative study among scientists working across 3 continents has found a strong association between circulating free DNA in patients being treated with olaparib (Lynparza) for prostate cancer and disease outcome.
Site Logo
June 19th 2017

The Road to Parenthood After Cancer

Samantha Eisenstein Watson, MBA
Young adult cancer survivors face an uncertain path to parenthood-here is one story.
Site Logo
June 19th 2017

European Commission Approves Second Biosimilar for Cancer Treatment Rituximab

Christina Mattina
The European Commission has approved Rixathon, a biosimilar of the cancer drug rituximab, for use in Europe, according to an announcement from Novartis, whose Sandoz division manufactures the biosimilar.
<1
...
697071727374757677
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo